System to screen and purify active ingredients from herbal medicines using hydrogel‐modified human umbilical vein endothelial cell membrane chromatography coupled with semi‐preparative high‐performance liquid chromatography‐offline‐high‐performance liquid chromatography‐mass spectrometry

Analytical screening and validation systems based on a combination of cell membrane chromatography and two‐dimensional chromatography‐tandem mass spectrometry are incapable of providing prepared samples containing the active ingredients found in traditional Chinese medicine; therefore, these samples cannot be directly used in subsequent studies. In this study, a semi‐preparative cell membrane chromatography column was developed using a hydrogel‐modified carrier and human umbilical vein endothelial cells to optimize prepared conditions, such as hydrogel polymerization, cell fragmentation, and cell membrane volume. This increased the binding ratio of membrane protein and carrier to 15.79 mg/g. The column was systematically evaluated using multitarget tyrosine kinase inhibitors that displayed good specificity and reproducibility. Subsequently, using the column coupled with a semi‐preparative high‐performance liquid chromatography‐offline‐high‐performance liquid chromatography‐mass spectrometry system, 15 active ingredients were screened and purified from Indigo naturalis , and five main components were identified: l ‐lysine, oxyresveratrol, tryptanthrin, isorhamnetin, and indirubin. Furthermore, the pharmacological effects of the ingredients were confirmed using cell proliferation and apoptosis assays. Results revealed potent proliferation‐inhibiting and apoptosis‐promoting abilities on human chronic myelogenous leukemic cells and human promyelocytic leukemic cells ( p < 0.001). Overall, the system presented screening and purification functions that could be used to prepare I. naturalis samples acting on the epidermal growth factor receptor and vascular endothelial cell growth factor.